| 注册
首页|期刊导航|中国肿瘤生物治疗杂志|TRAIL联合紫杉醇对人脑胶质瘤U87细胞的抑制效应及其可能的机制

TRAIL联合紫杉醇对人脑胶质瘤U87细胞的抑制效应及其可能的机制

仇波 吴鹏飞 王勇 陶钧 欧绍武 王运杰

中国肿瘤生物治疗杂志2013,Vol.20Issue(1):43-47,5.
中国肿瘤生物治疗杂志2013,Vol.20Issue(1):43-47,5.DOI:10.3872/j.issn.1007-385X.2013.01.007

TRAIL联合紫杉醇对人脑胶质瘤U87细胞的抑制效应及其可能的机制

Inhibitory effects of paclitaxel combined with TRAIL on human glioma U87 cells and the possible mechanism

仇波 1吴鹏飞 1王勇 1陶钧 1欧绍武 1王运杰1

作者信息

  • 1. 中国医科大学附属第一医院神经外科,辽宁沈阳,110001
  • 折叠

摘要

Abstract

Objective: To investigate the inhibitory effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) combined with paclitaxel treatment on human glioma U87 cells and the possible mechanism. Methods: MTT assay was used to detect the proliferation inhibitory rates of U87 cells in the paclitaxel group, TRAIL group, and TRAIL/ paclitaxel combination group, and flow cytometry was used to detect the effects of different treatments on apoptosis of U87 cells. The expression levels of TRAIL death receptor (DR) 4, DR5, caspase-8 and caspase-3 in U87 cells after different treatments were measured by Western blotting. Results: MTT results showed the TRAIL or paclitaxel used alone demonstrated a favorable inhibitory effect on proliferation of U87 cells in a concentration-dependent manner. Combined application of TRAIL (500 ng/ml) and paclitaxel (0.5 μmol/L) showed a synergistic inhibitory effect on the proliferation of U87 cells with the coefficient of drug interaction ( CDI) being 0. 59. The proliferation inhibitory rate of U87 cells in the combination group was significantly higher than that in the TRAIL or paclitaxel used alone groups ([70.24 ±3. 68] % vs [ 27. 01 ± 2. 36 ] % , [21.31 ±4. 85] % , P <0. 01) . The apoptotic rate of U87 cells in the TRAIL/paclitaxel combination group was significantly higher than that in the control group, TRAIL group, or paclitaxel group ( [ 67. 67 ± 2.46 ] % vs [ 1. 80 ± 1. 13 ] % , [22. 13 ±2. 18] % , [ 35. 90 ± 2. 53 ] % , P < 0. 01). The up-regulation expressions DR4,caspase-8 and caspase-3 in U87 cells was more obvious in TRAIL/paclitaxel combination treatment group than that in the TRAIL or paclitaxel groups ( P < 0. 05 ) . However, no obvious change in DR5 expression was observed ( P > 0. 05 ) . Conclusion: TRAIL combined with paclitaxel treatment can up-regulate DR4, caspase-8 and caspase-3 expressions, thereby inhibiting the proliferation and inducing the apoptosis of U87 cells.

关键词

脑胶质瘤/U87细胞/肿瘤坏死因子相关凋亡配体/紫杉醇/凋亡

Key words

glioma/ U87 cell/ TRAIL/ paclitaxel/ apoptosis

分类

医药卫生

引用本文复制引用

仇波,吴鹏飞,王勇,陶钧,欧绍武,王运杰..TRAIL联合紫杉醇对人脑胶质瘤U87细胞的抑制效应及其可能的机制[J].中国肿瘤生物治疗杂志,2013,20(1):43-47,5.

基金项目

国家自然科学基金资助(No.81000565). (No.81000565)

中国肿瘤生物治疗杂志

OA北大核心CSCDCSTPCD

1007-385X

访问量0
|
下载量0
段落导航相关论文